Search Orphan Drug Designations and Approvals
-
Generic Name: | midazolam |
---|---|
Date Designated: | 05/08/2006 |
Orphan Designation: | Treatment of bouts of increased seizure activity in selected refractory patients with epilepsy who are on stable regimens of anti-epileptic drugs and who require intermittent use of midazolam |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
UCB, Inc 1950 Lake Park rive Smyrna, Georgia 30080 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-